KWON YOUNG
SEC CIK 1733094 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ADMA | ADMA BIOLOGICS, INC. | Dir | 263.0K | $197.5K | $1.10M | 8 | 2021-10-25 | 2026-02-09 |
Most active insiders at ADMA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Grossman Adam S | Pres, CEO, Dir | — | $1.74M |
| 2 | Grossman Jerrold B | Dir | $250.9K | — |
| 3 | ELMS STEVE | Dir | $217.4K | — |
| 4 | Kestenberg-Messina Kaitlin M. | COO, SVP, Compliance | — | $157.8K |
| 5 | Tade Brad L. | CFO, Treas | — | — |
| 6 | Salas Eduardo Rene | Dir | — | — |
| 7 | Kohler Terry | CFO, Treas | — | — |
| 8 | KWON YOUNG | Dir | — | — |
| 9 | FINGER ALISON CECILY | Dir | — | — |
| 10 | Guiheen Lawrence P. | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-11 | 2026-02-09 | ADMA | ADMA BIOLOGICS, INC. | KWON YOUNG | Dir | A - Grant | $0.00 | +10.7K | 263.0K | +4% | $0 |
| D | 2025-02-21 | 2025-02-19 | ADMA | ADMA BIOLOGICS, INC. | KWON YOUNG | Dir | A - Grant | $0.00 | -10.9K | 252.3K | -4% | $0 |
| 2024-08-27 | 2024-08-23 | ADMA | ADMA BIOLOGICS, INC. | KWON YOUNG | Dir | S - Sale | $18.26 | -60.0K | 241.4K | -20% | -$1.10M | |
| D | 2024-02-28 | 2024-02-26 | ADMA | ADMA BIOLOGICS, INC. | KWON YOUNG | Dir | A - Grant | $0.00 | +24.0K | 301.4K | +9% | $0 |
| 2023-08-24 | 2023-08-24 | ADMA | ADMA BIOLOGICS, INC. | KWON YOUNG | Dir | P - Purchase | $3.90 | +25.0K | 277.4K | +10% | +$97.5K | |
| D | 2023-03-08 | 2023-03-06 | ADMA | ADMA BIOLOGICS, INC. | KWON YOUNG | Dir | A - Grant | $0.00 | +25.8K | 252.4K | +11% | $0 |
| D | 2022-03-09 | 2022-03-07 | ADMA | ADMA BIOLOGICS, INC. | KWON YOUNG | Dir | A - Grant | $0.00 | +26.6K | 226.6K | +13% | $0 |
| 2021-10-26 | 2021-10-25 | ADMA | ADMA BIOLOGICS, INC. | KWON YOUNG | Dir | P - Purchase | $1.00 | +100.0K | 200.0K | +100% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations